Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Net Margin (2016 - 2026)

Champions Oncology has reported Net Margin over the past 17 years, most recently at 1.68% for Q1 2026.

  • Quarterly results put Net Margin at 1.68% for Q1 2026, down 2807.0% from a year ago — trailing twelve months through Jan 2026 was 4.04% (down 1501.0% YoY), and the annual figure for FY2025 was 8.26%, up 2276.0%.
  • Net Margin for Q1 2026 was 1.68% at Champions Oncology, down from 1.58% in the prior quarter.
  • Over the last five years, Net Margin for CSBR hit a ceiling of 26.38% in Q1 2025 and a floor of 21.05% in Q1 2024.
  • Median Net Margin over the past 5 years was 2.32% (2022), compared with a mean of 4.42%.
  • Biggest five-year swings in Net Margin: skyrocketed 4743bps in 2025 and later crashed -2807bps in 2026.
  • Champions Oncology's Net Margin stood at 0.11% in 2022, then crashed by -15872bps to 17.9% in 2023, then surged by 130bps to 5.4% in 2024, then plummeted by -71bps to 1.58% in 2025, then crashed by -207bps to 1.68% in 2026.
  • The last three reported values for Net Margin were 1.68% (Q1 2026), 1.58% (Q4 2025), and 3.33% (Q3 2025) per Business Quant data.